CONMED Corporation Company Profile (NASDAQ:CNMD)

About CONMED Corporation

CONMED Corporation logoCONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CNMD
  • CUSIP: 20741010
Key Metrics:
  • Previous Close: $42.66
  • 50 Day Moving Average: $43.55
  • 200 Day Moving Average: $42.12
  • 52-Week Range: $36.42 - $50.16
  • Trailing P/E Ratio: 82.04
  • Foreward P/E Ratio: 20.03
  • P/E Growth: 3.68
  • Market Cap: $1.19B
  • Outstanding Shares: 27,832,000
  • Beta: 0.77
  • Net Margins: 1.92%
  • Return on Equity: 8.38%
  • Return on Assets: 3.65%
  • Debt-to-Equity Ratio: 0.84%
  • Current Ratio: 2.90%
  • Quick Ratio: 1.71%
Additional Links:
Companies Related to CONMED Corporation:

Analyst Ratings

Consensus Ratings for CONMED Corporation (NASDAQ:CNMD) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $45.50 (6.66% upside)

Analysts' Ratings History for CONMED Corporation (NASDAQ:CNMD)
DateFirmActionRatingPrice TargetDetails
2/2/2017Needham & Company LLCReiterated RatingBuy$48.00View Rating Details
11/23/2016Leerink SwannReiterated RatingHold -> NeutralView Rating Details
11/17/2015Deutsche Bank AGReiterated RatingBuyView Rating Details
10/22/2015Northland SecuritiesLower Price TargetMarket Perform$58.00 -> $44.00View Rating Details
10/12/2015Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$55.00View Rating Details
8/27/2015Piper Jaffray CompaniesReiterated RatingNeutral$51.00View Rating Details
5/15/2015Northland Capital PartnersInitiated CoverageOutperform$65.00View Rating Details
3/16/2015KeyCorpInitiated CoverageSector WeightView Rating Details
(Data available from 2/25/2015 forward)


Earnings History for CONMED Corporation (NASDAQ:CNMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/1/2017Q416$0.56$0.54$204.04 million$204.10 millionViewListenView Earnings Details
10/27/2016Q316$0.40$0.41$180.13 million$184.79 millionViewListenView Earnings Details
7/27/2016Q216$0.46$0.47$191.48 million$193.40 millionViewListenView Earnings Details
4/27/2016Q116$0.41$0.42$180.15 million$181.20 millionViewListenView Earnings Details
1/27/2016Q415$0.51$0.52$191.03 million$191.00 millionViewListenView Earnings Details
10/21/2015Q315$0.43$0.38$173.96 million$169.20 millionViewListenView Earnings Details
7/21/2015Q215$0.44$0.36$182.40 million$181.00 millionViewListenView Earnings Details
4/22/2015Q115$0.43$0.42$176.16 million$177.90 millionViewListenView Earnings Details
1/27/2015Q414$0.54$0.53$196.00 million$195.00 millionViewListenView Earnings Details
10/23/2014Q314$0.39$0.44$173.30 million$175.00 millionViewListenView Earnings Details
7/23/2014Q214$0.47$0.47$190.62 million$188.20 millionViewListenView Earnings Details
4/24/2014Q1$0.47$0.49$191.95 million$181.90 millionViewListenView Earnings Details
2/13/2014Q413$0.49$0.53$197.24 million$203.40 millionViewListenView Earnings Details
10/24/2013Q313$0.40$0.40$186.20 million$179.30 millionViewListenView Earnings Details
7/24/2013Q2 2013$0.44$0.43$193.55 million$193.00 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.45$0.45$196.79 million$187.00 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.50$0.52$200.12 million$201.20 millionViewListenView Earnings Details
10/25/2012$0.40$0.43ViewN/AView Earnings Details
7/26/2012$0.45$0.43ViewN/AView Earnings Details
4/26/2012$0.44$0.43ViewN/AView Earnings Details
2/15/2012$0.39$0.46ViewN/AView Earnings Details
10/27/2011$0.31$0.33ViewN/AView Earnings Details
7/28/2011$0.35$0.35ViewN/AView Earnings Details
4/28/2011$0.31$0.37ViewN/AView Earnings Details
2/3/2011$0.36$0.36ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CONMED Corporation (NASDAQ:CNMD)
Current Year EPS Consensus Estimate: $1.89 EPS
Next Year EPS Consensus Estimate: $2.13 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.37$0.52$0.44
Q2 20164$0.44$0.49$0.46
Q3 20162$0.40$0.41$0.41
Q4 20162$0.55$0.59$0.57
Q1 20172$0.30$0.37$0.34
Q2 20172$0.41$0.47$0.44
Q3 20172$0.40$0.49$0.45
Q4 20172$0.66$0.71$0.69
(Data provided by Zacks Investment Research)


Current Dividend Information for CONMED Corporation (NASDAQ:CNMD)
Annual Dividend:$0.80
Dividend Yield:1.88%
Payout Ratio:153.85% (Based on Trailing 12 Months of Earnings)
42.33% (Based on Current Year Consensus EPS Estimate)
37.56% (Based on Next Year Consensus EPS Estimate)

Dividend History for CONMED Corporation (NASDAQ:CNMD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CONMED Corporation (NASDAQ:CNMD)
Insider Ownership Percentage: 1.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2017Charles FarkasDirectorBuy305$44.65$13,618.25View SEC Filing  
11/8/2016Daniel JonasEVPSell1,500$41.78$62,670.00View SEC Filing  
11/7/2016Daniel JonasEVPSell2,555$40.40$103,222.00View SEC Filing  
10/3/2016Charles FarkasDirectorBuy336$40.04$13,453.44View SEC Filing  
7/1/2016Charles FarkasDirectorBuy282$47.87$13,499.34View SEC Filing  
6/3/2016Luke A PomilioCFOSell4,400$41.56$182,864.00View SEC Filing  
4/1/2016Charles FarkasDirectorBuy338$42.04$14,209.52View SEC Filing  
3/4/2016Mark D SnyderEVPSell2,940$41.32$121,480.80View SEC Filing  
3/2/2016John L WorkmanDirectorBuy2,500$39.85$99,625.00View SEC Filing  
2/19/2016Jerome J LandeDirectorSell1,630,800$38.28$62,427,024.00View SEC Filing  
1/4/2016Charles FarkasDirectorBuy332$42.18$14,003.76View SEC Filing  
12/11/2015David M BronsonDirectorBuy1,500$41.01$61,515.00View SEC Filing  
6/12/2015Jo Ann GoldenDirectorSell1,000$56.03$56,030.00View SEC Filing  
5/29/2015Stephen MandiaDirectorSell14,000$55.62$778,680.00View SEC Filing  
5/6/2015Pat BeyerInsiderBuy5,000$53.36$266,800.00View SEC Filing  
4/30/2015Stephen MandiaDirectorSell3,899$49.97$194,833.03View SEC Filing  
12/12/2014Stephen MandiaDirectorSell4,500$43.23$194,535.00View SEC Filing  
12/1/2014Dirk KuyperDirectorSell1,000$42.85$42,850.00View SEC Filing  
11/19/2014Joseph G DarlingEVPSell4,270$42.00$179,340.00View SEC Filing  
10/29/2014Robert D Shallish JrCFOSell10,410$41.67$433,784.70View SEC Filing  
9/4/2014William AbrahamEVPSell16,062$39.91$641,034.42View SEC Filing  
8/26/2014William AbrahamEVPSell7,423$38.36$284,746.28View SEC Filing  
8/21/2014William AbrahamEVPSell15,986$37.71$602,832.06View SEC Filing  
8/19/2014William AbrahamEVPSell5,312$37.75$200,528.00View SEC Filing  
7/31/2014Curt R HartmanCEOBuy10,000$39.25$392,500.00View SEC Filing  
7/30/2014Bruce DanielsDirectorSell1,600$39.31$62,896.00View SEC Filing  
7/30/2014Joseph J CorasantiCEOSell109,035$39.25$4,279,623.75View SEC Filing  
10/29/2013Joseph J CorasantiCEOSell80,148$36.47$2,922,997.56View SEC Filing  
10/28/2013Bruce DanielsDirectorSell4,500$36.43$163,935.00View SEC Filing  
9/13/2013Joseph CorasantiCEOSell44,852$33.04$1,481,910.08View SEC Filing  
9/11/2013William AbrahamSVPSell7,423$33.48$248,522.04View SEC Filing  
8/15/2013Dirk KuyperDirectorBuy1,000$31.63$31,630.00View SEC Filing  
6/7/2013Daniel JonasVPSell2,000$32.42$64,840.00View SEC Filing  
6/4/2013Heather L CohenVPSell1,200$32.59$39,108.00View SEC Filing  
5/31/2013Luke A PomilioVPSell2,556$33.19$84,833.64View SEC Filing  
5/29/2013Heather L CohenVPSell4,514$34.31$154,875.34View SEC Filing  
5/28/2013Robert D Shallish JrCFOSell10,000$34.35$343,500.00View SEC Filing  
2/15/2013Stuart J SchwartzDirectorSell1,000$30.32$30,320.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CONMED Corporation (NASDAQ:CNMD)
DateHeadline logoSpecial Notice - Notice of Intent: Brand Name Only CONMED Corporation medical equipment repair parts (NASDAQ:CNMD) - February 13 at 10:06 PM logoCONMED Corp. :CNMD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 7, 2017 (NASDAQ:CNMD) - February 7 at 5:28 PM logoETFs with exposure to CONMED Corp. : February 6, 2017 (NASDAQ:CNMD) - February 6 at 4:28 PM logoEdited Transcript of CNMD earnings conference call or presentation 1-Feb-17 9:30pm GMT (NASDAQ:CNMD) - February 2 at 9:49 PM logoCONMED CORPORATION (NASDAQ:CNMD) Files An 8-K Results of Operations and Financial Condition (NASDAQ:CNMD) - February 2 at 4:44 PM logoCONMED Corp. :CNMD-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017 (NASDAQ:CNMD) - February 2 at 4:44 PM logoCONMED's (CNMD) CEO Curt Hartman on Q4 2016 Results - Earnings Call Transcript (NASDAQ:CNMD) - February 2 at 2:44 AM logoConmed misses Street 4Q forecasts (NASDAQ:CNMD) - February 1 at 9:42 PM logoQ4 2016 Conmed Corp Earnings Release - After Market Close (NASDAQ:CNMD) - February 1 at 4:42 PM logoCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : February 1, 2017 (NASDAQ:CNMD) - February 1 at 4:42 PM logoCONMED Corp. : CNMD-US: Dividend Analysis : December 15th, 2016 (record date) : By the numbers : February 1, 2017 (NASDAQ:CNMD) - February 1 at 4:42 PM logoCONMED Corporation Announces Fourth Quarter and Fiscal Year 2016 Financial Results (NASDAQ:CNMD) - February 1 at 4:42 PM logoConmed Corp Earnings Call scheduled for 4:30 pm ET today (NASDAQ:CNMD) - February 1 at 4:42 PM logoMean Rating Of CONMED Corporation (NASDAQ:CNMD) At $2.17 (NASDAQ:CNMD) - January 30 at 7:42 AM logoCONMED Corporation to Present at the Leerink Partners 6th Annual Global Healthcare Conference (NASDAQ:CNMD) - January 26 at 5:29 PM logoCONMED Corp.: Get Out (NASDAQ:CNMD) - January 25 at 10:34 PM logoCONMED : Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXact™ (NASDAQ:CNMD) - January 19 at 5:38 PM logoCONMED Corp. – Value Analysis (NASDAQ:CNMD) : January 19, 2017 (NASDAQ:CNMD) - January 19 at 5:38 PM logoBovie Medical up 6% premarket on CONMED deal for PlazXact Ablator (NASDAQ:CNMD) - January 19 at 9:38 AM logoCONMED Corp. breached its 50 day moving average in a Bearish Manner : CNMD-US : January 18, 2017 (NASDAQ:CNMD) - January 18 at 4:42 PM logoCONMED Corporation to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on February 1, 2017 (NASDAQ:CNMD) - January 17 at 5:14 PM
News IconIOF invade home, shoot Palestinian man in front of mother (NASDAQ:CNMD) - January 11 at 3:10 AM
News IconFormer India captain Sourav Ganguly receives death threat (NASDAQ:CNMD) - January 10 at 10:08 PM
News IconCONMED Corporation (CNMD) Shares Bought by Bank of New York Mellon Corp (NASDAQ:CNMD) - January 10 at 10:08 PM logoResearch Analysts Set CONMED Corporation (NASDAQ:CNMD) Price Target at $48.6 (NASDAQ:CNMD) - January 9 at 10:35 PM
News IconDirector of CONMED Corporation (NASDAQ:CNMD), Farkas Charles, buys 305 shares worth $13,618 (NASDAQ:CNMD) - January 4 at 10:27 PM logoCONMED Corporation (NASDAQ:CNMD) Quarterly EPS At $0.41 (NASDAQ:CNMD) - January 1 at 4:22 PM logoCONMED Corporation to Present at the J.P. Morgan Healthcare Conference (NASDAQ:CNMD) - December 22 at 4:32 PM logoETFs with exposure to CONMED Corp. : December 14, 2016 (NASDAQ:CNMD) - December 14 at 5:25 PM logoIs CONMED Corporation (CNMD) a Good Stock to Buy? (NASDAQ:CNMD) - December 10 at 4:21 PM logoCONMED Corporation (NASDAQ:CNMD) EPS Target Set At $0.57 (NASDAQ:CNMD) - November 30 at 4:30 PM logoCONMED CORPORATION (NASDAQ:CNMD) Files An 8-K Other Events (NASDAQ:CNMD) - November 23 at 1:23 PM logoCONMED Corporation Announces Quarterly Cash Dividend (NASDAQ:CNMD) - November 21 at 4:34 PM logoETFs with exposure to CONMED Corp. : November 18, 2016 (NASDAQ:CNMD) - November 18 at 1:30 PM
News IconHow This Fund’s Investments in NorthStar Asset Management (NSAM), CONMED Corporation (CNMD) & Other Stocks Performed in Q3? (NASDAQ:CNMD) - November 18 at 1:01 PM logoCONMED Corp. :CNMD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016 (NASDAQ:CNMD) - November 17 at 3:32 PM logoConmed (CNMD) Passes Through 2% Yield Mark (NASDAQ:CNMD) - November 10 at 10:45 AM
News IconInsider Filing On Watch: Daniel Jonas Sold 1,500 Shares of CONMED Corporation (NASDAQ:CNMD) (NASDAQ:CNMD) - November 10 at 10:45 AM
News IconInsider Filing Worth Mentioning: The Insider, Daniel Jonas Unloaded 2,555 Shares of CONMED Corporation (NASDAQ:CNMD) (NASDAQ:CNMD) - November 9 at 11:27 AM logoCONMED CORP Financials (NASDAQ:CNMD) - November 3 at 3:48 PM logoCONMED (CNMD) Q3 Earnings Meet Estimates, Improve Y/Y (NASDAQ:CNMD) - October 31 at 10:16 AM logoCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : October 31, 2016 (NASDAQ:CNMD) - October 31 at 10:16 AM logoConmed : meets 3Q profit forecasts (NASDAQ:CNMD) - October 29 at 11:48 AM logoCONMED Corporation Announces Third Quarter 2016 Financial Results (NASDAQ:CNMD) - October 27 at 9:50 PM logoConmed Corp. Reveals 9% Increase In Q3 Earnings (NASDAQ:CNMD) - October 27 at 9:50 PM logoConmed meets 3Q profit forecasts (NASDAQ:CNMD) - October 27 at 9:50 PM logoCONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:CNMD) - October 27 at 4:36 PM logoQ3 2016 Conmed Corp Earnings Release - After Market Close (NASDAQ:CNMD) - October 27 at 8:51 AM logoCONMED Corp. : CNMD-US: Dividend Analysis : September 15th, 2016 (record date) : By the numbers : October 21, 2016 (NASDAQ:CNMD) - October 21 at 4:21 PM logoCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : October 19, 2016 (NASDAQ:CNMD) - October 19 at 9:14 AM


What is CONMED Corporation's stock symbol?

CONMED Corporation trades on the NASDAQ under the ticker symbol "CNMD."

How often does CONMED Corporation pay dividends? What is the dividend yield for CONMED Corporation?

CONMED Corporation announced a quarterly dividend on Monday, November 21st. Investors of record on Thursday, December 15th will be given a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 dividend on an annualized basis and a yield of 1.88%. The ex-dividend date of this dividend is Tuesday, December 13th.

Where is CONMED Corporation's stock going? Where will CONMED Corporation's stock price be in 2017?

2 analysts have issued 12-month price targets for CONMED Corporation's stock. Their forecasts range from $43.00 to $48.00. On average, they expect CONMED Corporation's share price to reach $45.50 in the next twelve months.

When will CONMED Corporation announce their earnings?

CONMED Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

What are analysts saying about CONMED Corporation stock?

Here are some recent quotes from research analysts about CONMED Corporation stock:

  • Needham & Company LLC analysts commented, "CNMD’s 4Q16 revenue beat and EPS missed consensus and management’s revenue and EPS guidance were below consensus due partly to an increased currency headwind. Positives include SurgiQuest sales which beat our estimate ($20M vs. $19M) and strong international growth while negatives included double-digit declines in domestic Orthopedic Surgery and Surgical Visualization which caused overall organic growth to slow from 3Q16." (2/2/2017)

  • According to Zacks Investment Research, "Over the past six months CONMED Corporation has outperformed the broader industry trends in terms of price performance. However, a falling estimate revision trend for the next year indicates looming concerns ahead. Foreign exchange movements have been unfavorably impacting the company’s results of late. Additionally, CONMED operates in a highly competitive environment which is likely to mar the top-line growth. Declining Orthopaedic surgery sales, especially in the U.S. in the last reported quarter is an added concern. Meanwhile, the company reported impressive third-quarter 2016 results wherein revenues surpassed the Zacks Consensus Estimate and increased on a year-over-year basis. The earnings were in-line with the estimate mark." (12/19/2016)

  • Leerink Swann analysts commented, "We remain cautious on the company’s ability to manage through what we believe could be meaningful top-line headwinds in F2H17 and FY2018 in order to return to and sustain a solid mid- single-digit growth trajectory after just 3% growth in F2Q17, including: (1) A competitive CRM (cardiac rhythm management) product cycle, (2) Current and upcoming competitive launches in DES (drug eluting stents), (3) Potential modest share loss in U.S. TAVR (transcatheter aortic valve replacement) with a competitor recently receiving an expanded indication that is likely ~12-18 months ahead of MDT only partially offset by MDT’s recent large valve size launch; and (4) Continued share loss in Neuromodulation, particularly in SCS (spinal cord stimulation), DBS (deep brain stimulation), and implantable drug infusion pumps." (11/23/2016)

Who owns CONMED Corporation stock?

CONMED Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.44%), Champlain Investment Partners LLC (5.33%), State Street Corp (2.27%), William Blair Investment Management LLC (1.57%), Westwood Holdings Group Inc. (0.90%) and Netols Asset Management Inc. (0.59%). Company insiders that own CONMED Corporation stock include Charles Farkas, Daniel Jonas, David M Bronson, Jerome J Lande, Jo Ann Golden, John L Workman, Luke A Pomilio, Mark D Snyder, Pat Beyer and Stephen Mandia.

Who sold CONMED Corporation stock? Who is selling CONMED Corporation stock?

CONMED Corporation's stock was sold by a variety of institutional investors in the last quarter, including Westwood Holdings Group Inc., Folger Hill Asset Management LP, Champlain Investment Partners LLC, GSA Capital Partners LLP, Dimensional Fund Advisors LP, Continental Advisors LLC, AQR Capital Management LLC and William Blair Investment Management LLC. Company insiders that have sold CONMED Corporation stock in the last year include Daniel Jonas, Luke A Pomilio and Mark D Snyder.

Who bought CONMED Corporation stock? Who is buying CONMED Corporation stock?

CONMED Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp, Netols Asset Management Inc., Zebra Capital Management LLC, Dynamic Technology Lab Private Ltd, Bayesian Capital Management LP, Keybank National Association OH and Comerica Bank. Company insiders that have bought CONMED Corporation stock in the last two years include Charles Farkas, David M Bronson, John L Workman and Pat Beyer.

How do I buy CONMED Corporation stock?

Shares of CONMED Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CONMED Corporation stock cost?

One share of CONMED Corporation stock can currently be purchased for approximately $42.66.

CONMED Corporation (NASDAQ:CNMD) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for CONMED Corporation (NASDAQ:CNMD)

Earnings History Chart

Earnings by Quarter for CONMED Corporation (NASDAQ:CNMD)

Dividend History Chart

Dividend Payments by Quarter for CONMED Corporation (NASDAQ:CNMD)

Last Updated on 2/25/2017 by Staff